293 related articles for article (PubMed ID: 19371742)
21. Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats.
Wen H; Jiang H; Lu Z; Hu X; He B; Tang Q; Huang C
Biomed Pharmacother; 2010 Sep; 64(7):446-50. PubMed ID: 20359859
[TBL] [Abstract][Full Text] [Related]
22. Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells.
Onay-Besikci A; Suzmecelik E; Ozcelikay AT
Can J Physiol Pharmacol; 2012 Aug; 90(8):1087-93. PubMed ID: 22524679
[TBL] [Abstract][Full Text] [Related]
23. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
Bogaard HJ; Natarajan R; Mizuno S; Abbate A; Chang PJ; Chau VQ; Hoke NN; Kraskauskas D; Kasper M; Salloum FN; Voelkel NF
Am J Respir Crit Care Med; 2010 Sep; 182(5):652-60. PubMed ID: 20508210
[TBL] [Abstract][Full Text] [Related]
24. Effect of carvedilol on atrioventricular conduction in the ischemic heart.
Horio T; Ito S; Aoyama M; Takeda Y; Suzumura H; Nakata K; Yamada Y; Suzuki S; Fukutomi T; Itoh M
Eur J Pharmacol; 2001 Jan; 412(2):145-53. PubMed ID: 11165226
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
[TBL] [Abstract][Full Text] [Related]
26. Myocardial protection with carvedilol.
Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
[TBL] [Abstract][Full Text] [Related]
27. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Anand Swarup KR; Johns EJ
Auton Autacoid Pharmacol; 2011; 31(1-2):13-20. PubMed ID: 21166975
[TBL] [Abstract][Full Text] [Related]
28. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
Nishio R; Shioi T; Sasayama S; Matsumori A
J Am Coll Cardiol; 2003 Jan; 41(2):340-5. PubMed ID: 12535832
[TBL] [Abstract][Full Text] [Related]
29. Characteristic effects of alpha1-beta1,2-adrenergic blocking agent, carvedilol, on [Ca2+]i in ventricular myocytes compared with those of timolol and atenolol.
Yao A; Kohmoto O; Oyama T; Sugishita Y; Shimizu T; Harada K; Matsui H; Komuro I; Nagai R; Matsuo H; Serizawa T; Maruyama T; Takahashi T
Circ J; 2003 Jan; 67(1):83-90. PubMed ID: 12520158
[TBL] [Abstract][Full Text] [Related]
30. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
Giannattasio C; Cattaneo BM; Seravalle G; Carugo S; Mangoni AA; Grassi G; Zanchetti A; Mancia G
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S18-22. PubMed ID: 1378144
[TBL] [Abstract][Full Text] [Related]
31. Effects of adrenergic antagonists on LH surge in short-term ovariectomized-steroids-primed rats.
Pi WP
Proc Natl Sci Counc Repub China B; 1999 Jul; 23(3):120-5. PubMed ID: 10492893
[TBL] [Abstract][Full Text] [Related]
32. Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress.
Hanke ML; Powell ND; Stiner LM; Bailey MT; Sheridan JF
Brain Behav Immun; 2012 Oct; 26(7):1150-9. PubMed ID: 22841997
[TBL] [Abstract][Full Text] [Related]
33. Norepinephrine-induced changes in rat heart function, metabolism, and weight are antagonized by carvedilol.
Nagano T; O'Harrow S; Sponer G; Zimmer HG
J Cardiovasc Pharmacol; 1993 Apr; 21(4):530-6. PubMed ID: 7681896
[TBL] [Abstract][Full Text] [Related]
34. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Feuerstein G; Liu GL; Yue TL; Cheng HY; Hieble JP; Arch JR; Ruffolo RR; Ma XL
Eur J Pharmacol; 1998 Jun; 351(3):341-50. PubMed ID: 9721026
[TBL] [Abstract][Full Text] [Related]
35. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
Molenaar P; Christ T; Ravens U; Kaumann A
Cardiovasc Res; 2006 Jan; 69(1):128-39. PubMed ID: 16225854
[TBL] [Abstract][Full Text] [Related]
36. Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients.
Bakovic D; Pivac N; Eterovic D; Palada I; Valic Z; Paukovic-Sekulic B; Dujic Z
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):441-6. PubMed ID: 19702597
[TBL] [Abstract][Full Text] [Related]
37. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol blockade of rat myocardial alpha1-adrenoceptors.
Qvigstad E; Osnes JB; Sandnes D; Schiander I; Bøkenes J; Sjaastad I; Skomedal T
Eur J Pharmacol; 2003 Nov; 481(1):83-9. PubMed ID: 14637179
[TBL] [Abstract][Full Text] [Related]
39. Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Goyagi T; Kimura T; Nishikawa T; Tobe Y; Masaki Y
Anesth Analg; 2006 Sep; 103(3):658-63. PubMed ID: 16931677
[TBL] [Abstract][Full Text] [Related]
40. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
